Phreesia Investors with Significant Losses Can Lead Securities Fraud Lawsuit

Rosen Law Firm, a global investor rights law firm, has notified purchasers of Phreesia, Inc. (NYSE: PHR) common stock of a critical deadline to serve as lead plaintiff in a potential securities fraud class action. Investors who acquired Phreesia shares between May 8, 2025, and March 30, 2026, and incurred losses exceeding $100,000, are urged to come forward.

The lawsuit alleges that the company's management made false or misleading statements and concealed material adverse facts regarding slowing demand and weakening revenue streams, particularly affecting its Network Solutions segment due to reduced pharmaceutical marketing commitments. The plaintiffs claim that investors suffered damages when these undisclosed issues came to light.

Rosen Law Firm highlights that eligible investors may be entitled to compensation without incurring out-of-pocket costs through a contingency fee arrangement. To be considered for the role of lead plaintiff, a motion must be filed with the Court by July 13, 2026. The lead plaintiff acts as a representative party for all class members in directing the litigation.

The firm advises investors to select counsel with a proven track record. Rosen Law Firm specializes in securities class actions and shareholder derivative litigation, having recovered billions of dollars for investors in numerous cases.